Acumen Pharmaceuticals
ABOS
ABOS
57 hedge funds and large institutions have $106M invested in Acumen Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+5
Holders Change %
+9.62%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
25
Reduced
7
Closed
12
Calls
–
Puts
$78K
Net Calls
-$78K
Net Calls Change
-$78K
Top Buyers
| 1 |
GPP
1
Great Point Partners
Greenwich,
Connecticut
|
$3.63M |
| 2 |
2
BlackRock
New York
|
$15M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$4.83M |
| 4 |
DTC
4
Deep Track Capital
Greenwich,
Connecticut
|
$10.2M |
| 5 |
PA
5
Perceptive Advisors
New York
|
$2.33M |
